Meyka Pro banner
OptiNose, Inc.

OptiNose, Inc. Fundamental Analysis

OPTNNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$9.60
$0.00(0.00%)
U.S. Market opens in 16h 37m

OptiNose, Inc. Fundamental Analysis

OptiNose, Inc. (OPTN) shows moderate financial fundamentals with a PE ratio of -4.53, profit margin of -27.54%, and ROE of 33.93%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE33.93%
Cash Position86.64%
PEG Ratio0.13

Areas of Concern

Operating Margin-20.86%
Current Ratio0.77
We analyze OPTN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 60.7/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
60.7/100

We analyze OPTN's fundamental strength across five key dimensions:

Efficiency Score

Weak

OPTN struggles to generate sufficient returns from assets.

ROA > 10%
-16.73%

Valuation Score

Excellent

OPTN trades at attractive valuation levels.

PE < 25
-4.53
PEG Ratio < 2
0.13

Growth Score

Weak

OPTN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

OPTN shows balanced financial health with some risks.

Debt/Equity < 1
-3.20
Current Ratio > 1
0.77

Profitability Score

Weak

OPTN struggles to sustain strong margins.

ROE > 15%
33.93%
Net Margin ≥ 15%
-27.54%
Positive Free Cash Flow
No

Key Financial Metrics

Is OPTN Expensive or Cheap?

P/E Ratio

OPTN trades at -4.53 times earnings. This suggests potential undervaluation.

-4.53

PEG Ratio

When adjusting for growth, OPTN's PEG of 0.13 indicates potential undervaluation.

0.13

Price to Book

The market values OptiNose, Inc. at -2.42 times its book value. This may indicate undervaluation.

-2.42

EV/EBITDA

Enterprise value stands at -44.03 times EBITDA. This is generally considered low.

-44.03

How Well Does OPTN Make Money?

Net Profit Margin

For every $100 in sales, OptiNose, Inc. keeps $-27.54 as profit after all expenses.

-27.54%

Operating Margin

Core operations generate -20.86 in profit for every $100 in revenue, before interest and taxes.

-20.86%

ROE

Management delivers $33.93 in profit for every $100 of shareholder equity.

33.93%

ROA

OptiNose, Inc. generates $-16.73 in profit for every $100 in assets, demonstrating efficient asset deployment.

-16.73%

Following the Money - Real Cash Generation

Operating Cash Flow

OptiNose, Inc. generates limited operating cash flow of $-44.76M, signaling weaker underlying cash strength.

$-44.76M

Free Cash Flow

OptiNose, Inc. generates weak or negative free cash flow of $-44.62M, restricting financial flexibility.

$-44.62M

FCF Per Share

Each share generates $-4.41 in free cash annually.

$-4.41

FCF Yield

OPTN converts -46.03% of its market value into free cash.

-46.03%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.53

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.13

vs 25 benchmark

P/B Ratio

Price to book value ratio

-2.42

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.24

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-3.20

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.77

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.34

vs 25 benchmark

ROA

Return on assets percentage

-0.17

vs 25 benchmark

ROCE

Return on capital employed

0.48

vs 25 benchmark

How OPTN Stacks Against Its Sector Peers

MetricOPTN ValueSector AveragePerformance
P/E Ratio-4.5329.43 Better (Cheaper)
ROE33.93%426.00% Weak
Net Margin-27.54%-11473.00% (disorted) Weak
Debt/Equity-3.200.79 Strong (Low Leverage)
Current Ratio0.775.14 Weak Liquidity
ROA-16.73%-17.00% (disorted) Weak

OPTN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews OptiNose, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ